HCPCS Level IIdrugActive
J1203
Inj, cipaglucosidase, 5 mg
BETOS: O1E
Effective: 2024-04-01
Description
Injection, cipaglucosidase alfa-atga, 5 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Pombiliti
Manufacturer
Amicus Therapeutics US, LLC
HCPCS Dosage
5 MG
Billing Units
21.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.